GAMELIN ERICK (Chief Development Officer) sold 0.8% of their position (400.00 shares) of ACRIVON THERAPEUTICS, INC. on the open market
Open‑market sale worth $804.00 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0000905148-26-003838
Officer· Chief Development Officer
Since Mar 2026
-400.00
Net shares
Net seller
$804.00
Total sold
1
Open market trades
0B · 1S
1
Total transactions
400.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−400.00
Price / share
$2.01
Trade value
$804.00
% of position
0.8%
8/18/2026
52.99K→52.59K
Total
Net shares
−400.00
Net value
-$804.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −400.00 | $2.01 | $804.00 | 0.8% | 52.99K | 52.59K |
| Total | −400.00 | -$804.00 | ||||||
Derivative Transactions0
No derivative transactions reported